| Literature DB >> 29484135 |
Madhawa Neranjan Gunathilake1, Jeonghee Lee2, Young Ae Cho2, Jae Hwan Oh3, Hee Jin Chang3, Dae Kyung Sohn3, Aesun Shin4, Jeongseon Kim2.
Abstract
This study assessed the interaction between physical activity and colorectal cancer (CRC) risk based on a polymorphism in the paired-like homeodomain 1 (PITX1) gene in Koreans. In total, 923 cases and 1,846 controls were enrolled at the National Cancer Center, Korea. Subjects who did regular exercise showed a significantly reduced risk of CRC than those did not exercise regularly (OR = 0.37, 95% CI = 0.30-0.45). Subjects in the highest tertile of metabolic equivalents of task (MET)-minutes per week showed a significantly lower risk of CRC (OR = 0.62, 95% CI = 0.48-0.79, p-trend < 0.001). In the dominant model, minor allele carriers showed a significantly higher risk of CRC than subjects homozygous for the major allele (OR = 1.46, 95% CI = 1.18-1.80). The PITX1 genetic variant showed significant interactions with regular exercise and CRC risk (p-interaction = 0.018) and colon cancer risk (p-interaction = 0.029) among all subjects. Subjects who carried at least one minor allele and did not regularly exercise showed a greater risk of CRC (OR = 1.81, 95% CI = 1.37-2.41). Subjects who were homozygous for the major allele with high physical activity showed a significantly reduced risk of CRC (OR = 0.56, 95% CI = 0.38-0.82). Thus, individuals with PITX1 genetic variants can have benefit from physical activity regarding prevention of CRC risk in a Korean population.Entities:
Keywords: PITX1; colorectal cancer; genetic polymorphism; interaction; physical activity
Year: 2018 PMID: 29484135 PMCID: PMC5800927 DOI: 10.18632/oncotarget.24136
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
General characteristics of the study participants
| Control ( | Case ( | ||
|---|---|---|---|
| Age (years) | 56.1 ± 9.1 | 56.6 ± 9.7 | >0.999 |
| Gender [ | >0.999 | ||
| Male | 1250 (67.7) | 625 (67.7) | |
| Female | 596 (32.3) | 298 (32.3) | |
| Body mass index (kg/m2) [ | 24.1 ± 2.7 | 23.6 ± 3.4 | <0.001 |
| <25 | 1215 (66.2) | 639 (69.3) | 0.103 |
| ≥25 | 620 (33.8) | 283 (30.7) | |
| Smoking status [ | 0.156 | ||
| Non-smoker | 818 (44.3) | 409 (44.3) | |
| Former smoker | 687 (37.2) | 318 (34.5) | |
| Current smoker | 341 (18.5) | 196 (21.2) | |
| Alcohol consumption [ | <0.001 | ||
| Non-drinker | 560 (30.3) | 279 (30.2) | |
| Former drinker | 169 (9.2) | 129 (14.0) | |
| Current drinker | 1117 (60.5) | 515 (55.8) | |
| First degree family history of colorectal cancer (Yes) [ | 99 (5.4) | 86 (9.3) | <0.001 |
| Regular exercise [ | <0.001 | ||
| Yes | 1047 (58.2) | 311 (33.7) | |
| No | 753 (41.8) | 612 (66.3) | |
| Educational level [ | <0.001 | ||
| Elementary school or less | 127 (7.04) | 180 (19.5) | |
| Middle school | 155 (8.6) | 141 (15.3) | |
| High school | 587 (32.6) | 369 (40.0) | |
| College or more | 934 (51.8) | 233 (25.2) | |
| Occupation [ | <0.001 | ||
| Group1: Professionals, administrative management, office jobs | 481 (26.4) | 189 (20.5) | |
| Group2: Sales and service positions | 403 (21.8) | 38 (4.1) | |
| Group3: Agriculture, manufacturing, mining, army service | 241 (13.2) | 141 (15.3) | |
| Group4: Housekeeping, unemployment, and others | 698 (38.3) | 555 (60.1) | |
| Marital status [ | <0.001 | ||
| Married | 1654 (90.6) | 773 (84.1) | |
| Others (single, divorced, separated, widowed, cohabitating) | 171 (9.4) | 146 (15.9) | |
| Monthly income [ | <0.001 | ||
| <200 | 388 (23.0) | 321 (34.8) | |
| 200–400 | 754 (44.6) | 387 (41.9) | |
| ≥400 | 545 (32.3) | 215 (23.3) | |
| Physical activity [MET min per week]c | 2731.0 ± 2945.5 | 2236.7 ± 2025.3 | 0.098 |
| Low (<1059) | 612 (33.3) | 306 (33.2) | 0.002 |
| Moderate (1059–2772) | 584 (31.8) | 348 (37.8) | |
| High (≥2772) | 641 (34.9) | 267 (29.0) | |
| Total energy intake (kcal/day) | 1689.6 ± 560.4 | 2026.3 ± 534.0 | <0.001 |
aUnit is 10,000 Won in Korean currency.
bP-values present the difference between cases and controls. Age, body mass index (continuous) and total energy intake were examined using Student’s t-tests; Other variables were assessed using chi-square analysis.
cPhysical activity [MET min per week] was assessed using Mann-Whitney U test.
The association between physical activity and colorectal cancer risk stratified by gender and anatomical sites
| Colorectal cancer | Colon cancer | Rectal cancer | |||||
|---|---|---|---|---|---|---|---|
| Control (%) | Case (%) | OR (95% CI)a | Case (%) | OR (95% CI)a | Case (%) | OR (95% CI)a | |
| All | |||||||
| Regular exercise | |||||||
| No | 753 (41.8) | 612 (66.3) | 1.00 | 299 (64.6) | 1.00 | 301 (67.8) | 1.00 |
| Yes | 1047 (58.2) | 311 (33.7) | 0.37 (0.30–0.45) | 164 (35.4) | 0.38 (0.30–0.49) | 143 (32.2) | 0.36 (0.28–0.46) |
| Physical activity (MET-min/week) | |||||||
| Low (<1059) | 612 (33.3) | 306 (33.2) | 1.00 | 152 (32.9) | 1.00 | 146 (33.0) | 1.00 |
| Moderate (1059-<2871) | 612 (33.3) | 366 (39.7) | 1.02 (0.81–1.29) | 186 (40.3) | 1.03 (0.78–1.36) | 175 (39.5) | 1.03 (0.77–1.37) |
| High (≥2871) | 613 (33.4) | 249 (27.0) | 0.62 (0.48–0.79) | 124 (26.8) | 0.63 (0.47–0.85) | 122 (27.5) | 0.63 (0.46–0.86) |
| | <0.001 | 0.001 | <0.001 | ||||
| Male | |||||||
| Regular exercise | |||||||
| No | 489 (40.6) | 387 (61.9) | 1.00 | 175 (59.1) | 1.00 | 205 (64.1) | 1.00 |
| Yes | 716 (59.4) | 238 (38.1) | 0.45 (0.35–0.58) | 121 (40.9) | 0.48 (0.35–0.65) | 115 (35.9) | 0.44 (0.32–0.59) |
| Physical activity (MET-min/week) | |||||||
| Low (<1314) | 412 (33.2) | 215 (34.5) | 1.00 | 100 (33.9) | 1.00 | 110 (34.5) | 1.00 |
| Moderate (1314–<3390) | 415 (33.4) | 239 (38.4) | 0.81 (0.61–1.09) | 114 (33.4) | 0.80 (0.56–1.14) | 123 (38.6) | 0.83 (0.58–1.18) |
| High (≥3390) | 415 (33.4) | 169 (27.1) | 0.56 (0.41–0.76) | 81 (27.5) | 0.56 (0.38–0.82) | 86 (27.0) | 0.56 (0.39–0.83) |
| p-trend | <0.001 | 0.003 | 0.003 | ||||
| Female | |||||||
| Regular exercise | |||||||
| No | 264 (44.4) | 225 (75.5) | 1.00 | 124 (74.3) | 1.00 | 96 (77.4) | 1.00 |
| Yes | 331 (55.6) | 73 (24.5) | 0.26 (0.18–0.37) | 43 (25.8) | 0.27 (0.17–0.42) | 28 (22.6) | 0.24 (0.14–0.39) |
| Physical activity (MET-min/week) | |||||||
| Low (<735) | 198 (33.3) | 104 (34.9) | 1.00 | 63 (37.7) | 1.00 | 37 (29.8) | 1.00 |
| Moderate (735-<2128) | 198 (33.3) | 97 (32.6) | 0.85 (0.57–1.28) | 48 (28.7) | 0.67 (0.41–1.09) | 48 (38.7) | 1.23 (0.73–2.07) |
| High (≥2128) | 199 (33.5) | 97 (32.6) | 0.69 (0.46–1.05) | 56 (33.5) | 0.66 (0.41–1.06) | 39 (31.5) | 0.81 (0.47–1.40) |
| p-trend | 0.086 | 0.143 | 0.268 | ||||
aAdjusted for age, gender, marital status, occupation, income, education, BMI, smoking, alcohol, family history of CRC, total energy intake.
Association between PITX1 genetic polymorphism and colorectal cancer risk by anatomical sites
| All | Colorectal cancer | Colon cancer | Rectal cancer | ||||
|---|---|---|---|---|---|---|---|
| Control (%) | Case (%) | OR (95% CI)a | Case (%) | OR (95% CI)a | Case (%) | OR (95% CI)a | |
| Codominant model | |||||||
| CC | 673 (50.6) | 294 (42.8) | 1.00 | 146 (41.8) | 1.00 | 146 (44.4) | 1.00 |
| AC | 548 (41.2) | 321 (46.7) | 1.43 (1.15–1.76) | 166 (47.6) | 1.47 (1.12–1.92) | 149 (45.3) | 1.34 (1.01–1.77) |
| AA | 110 (8.3) | 72 (10.5) | 1.67 (1.16–2.39) | 37 (10.6) | 1.71 (1.08–2.70) | 34 (10.3) | 1.66 (1.03–2.68) |
| Dominant model | |||||||
| CC | 673 (50.5) | 294 (42.7) | 1.00 | 146 (41.8) | 1.00 | 146 (44.4) | 1.00 |
| AC/AA | 658 (49.4) | 393 (57.2) | 1.46 (1.18–1.80) | 203 (58.2) | 1.50 (1.16–1.95) | 183 (55.6) | 1.39 (1.06–1.82) |
| Recessive model | |||||||
| CC/AC | 1221 (91.7) | 615 (89.5) | 1.00 | 312 (89.4) | 1.00 | 295 (89.7) | 1.00 |
| AA | 110 (8.3) | 72 (10.5) | 1.43 (0.99–2.07) | 37 (10.6) | 1.41 (0.92–2.19) | 34 (10.3) | 1.44 (0.92–2.28) |
| Male | |||||||
| Codominant model | |||||||
| CC | 474 (52.1) | 206 (43.9) | 1.00 | 99 (43.2) | 1.00 | 106 (44.7) | 1.00 |
| AC | 361 (40.0) | 218 (46.5) | 1.40 (1.06–1.84) | 108 (47.2) | 1.44 (1.03–2.01) | 108 (45.6) | 1.35 (0.96–1.89) |
| AA | 75 (8.2) | 45 (9.6) | 1.60 (0.99–2.59) | 22 (9.6) | 1.61 (0.90–2.86) | 23 (9.7) | 1.61 (0.89–2.88) |
| Dominant model | |||||||
| CC | 474 (52.1) | 206 (43.9) | 1.00 | 99 (43.2) | 1.00 | 106 (44.7) | 1.00 |
| AC/AA | 436 (47.9) | 263 (56.1) | 1.43 (1.10–1.86) | 130 (56.8) | 1.47 (1.07–2.02) | 131 (55.3) | 1.39 (1.01–1.92) |
| Recessive model | |||||||
| CC/AC | 835 (91.8) | 424 (90.4) | 1.00 | 207 (90.4) | 1.00 | 214 (90.3) | 1.00 |
| AA | 75 (8.2) | 45 (9.6) | 1.36 (0.86–2.16) | 22 (9.6) | 1.35 (0.78–2.34) | 23 (9.7) | 1.40 (0.80–2.44) |
| Female | |||||||
| Codominant model | |||||||
| CC | 199 (47.3) | 88 (40.4) | 1.00 | 47 (39.2) | 1.00 | 40 (43.5) | 1.00 |
| AC | 187 (44.4) | 103 (47.3) | 1.44 (0.96–2.17) | 58 (48.3) | 1.54 (0.94–2.50) | 41 (44.6) | 1.30 (0.77–2.20) |
| AA | 35 (8.3) | 27 (12.4) | 1.88 (0.97–3.65) | 15 (12.5) | 1.86 (0.85–4.04) | 11 (12.0) | 1.79 (0.77–4.14) |
| Dominant model | |||||||
| CC | 199 (47.3) | 88 (40.4) | 1.00 | 47 (39.2) | 1.00 | 40 (43.5) | 1.00 |
| AC/AA | 222 (52.7) | 130 (59.6) | 1.51 (1.02–2.24) | 73 (60.8) | 1.59 (1.00–2.53) | 52 (56.5) | 1.38 (0.83–2.27) |
| Recessive model | |||||||
| CC/AC | 386 (91.7) | 191 (87.6) | 1.00 | 105 (87.5) | 1.00 | 81 (88.0) | 1.00 |
| AA | 35 (8.3) | 27 (12.4) | 1.56 (0.83–2.90) | 15 (12.5) | 1.48 (0.72–3.08) | 11 (12.0) | 1.57 (0.71–3.47) |
aAdjusted for age, gender, education, regular exercise, alcohol, family history of CRC, total energy intake.
Interaction between regular exercise and PITX1 genetic variant in the risk of CRC stratified by anatomical sites and gender
| Regular exercise | CC | AC/AA | |||
|---|---|---|---|---|---|
| No | Yes | No | Yes | ||
| Colorectal cancer | |||||
| All | |||||
| No. controls/cases | 295/197 | 373/97 | 239/265 | 417/128 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.39 (0.29–0.52) | 1.66 (1.29–2.13) | 0.46 (0.35–0.60) | 0.086 |
| Adjusted ORa (95% CI) | 1.00 (ref.) | 0.45 (0.32–0.62) | 1.81 (1.37–2.41) | 0.48 (0.36–0.65) | 0.018 |
| Male | |||||
| No. controls/cases | 191/132 | 278/74 | 149/169 | 285/94 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.39 (0.27–0.54) | 1.64 (1.20–2.24) | 0.48 (0.35–0.66) | 0.238 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 0.45 (0.30–0.66) | 1.69 (1.18–2.41) | 0.52 (0.36–0.75) | 0.173 |
| Female | |||||
| No. controls/cases | 104/65 | 95/23 | 90/96 | 132/34 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.39 (0.22–0.67) | 1.71 (1.12–2.61) | 0.41 (0.25–0.67) | 0.204 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 0.45 (0.24–0.83) | 1.99 (1.23–3.22) | 0.40 (0.23–0.70) | 0.055 |
| Colon cancer | |||||
| All | |||||
| No. controls/cases | 295/90 | 373/56 | 239/130 | 417/73 | |
| Crude OR (95% CI) | 1.00 (ref) | 0.49 (0.34–0.71) | 1.78 (1.30–2.45) | 0.57 (0.41–0.81) | 0.091 |
| Adjusted ORa (95% CI) | 1.00 (ref) | 0.57 (0.38–0.84) | 1.95 (1.38–2.75) | 0.38 (0.26–0.56) | 0.029 |
| Male | |||||
| No. controls/cases | 191/57 | 278/42 | 149/78 | 285/52 | |
| Crude OR (95% CI) | 1.00 (ref) | 0.51 (0.33–0.79) | 1.75 (1.17–2.63) | 0.61 (0.40–0.93) | 0.220 |
| Adjusted ORb (95% CI) | 1.00 (ref) | 0.58 (0.36–0.94) | 1.81 (1.17–2.80) | 0.67 (0.43–1.06) | 0.149 |
| Female | |||||
| No. controls/cases | 104/33 | 95/14 | 90/52 | 132/21 | |
| Crude OR (95% CI) | 1.00 (ref) | 0.46 (0.23–0.92) | 1.82 (1.08–3.06) | 0.50 (0.27–0.92) | 0.254 |
| Adjusted ORb (95% CI) | 1.00 (ref) | 0.53 (0.25–1.11) | 2.13 (1.20–3.78) | 0.48 (0.25–0.95) | 0.131 |
| Rectal cancer | |||||
| All | |||||
| No. controls/cases | 295/106 | 373/40 | 239/128 | 417/55 | |
| Crude OR (95% CI) | 1.00 (ref) | 0.30 (0.20–0.44) | 1.49 (1.10–2.03) | 0.37 (0.26–0.53) | 0.478 |
| Adjusted ORa (95% CI) | 1.00 (ref) | 0.34 (0.22–0.52) | 1.63 (1.17–2.29) | 0.38 (0.26–0.56) | 0.277 |
| Male | |||||
| No. controls/cases | 191/74 | 278/32 | 149/89 | 285/42 | |
| Crude OR (95% CI) | 1.00 (ref) | 0.30 (0.19–0.47) | 1.54 (1.06–2.24) | 0.38 (0.25–0.58) | 0.555 |
| Adjusted ORb (95% CI) | 1.00 (ref) | 0.35 (0.21–0.57) | 1.59 (1.05–2.40) | 0.41 (0.26–0.65) | 0.483 |
| Female | |||||
| No. controls/cases | 104/32 | 95/8 | 90/39 | 132/13 | |
| Crude OR | 1.00 (ref) | 0.27 (0.12–0.62) | 1.41 (0.82–2.43) | 0.32 (0.16–0.64) | 0.735 |
| Adjusted ORb | 1.00 (ref) | 0.33 (0.14–0.79) | 1.65 (0.92–2.97) | 0.33 (0.16–0.69) | 0.550 |
aAdjusted for age, gender, education, alcohol, family history of CRC, total energy intake.
bAdjusted for age, education, alcohol, family history of CRC, total energy intake.
Interaction between physical activity based on MET-minutes per week and PITX1 genetic variant in the risk of CRC stratified by anatomical sites and gender
| CC | AC/AA | ||||||
|---|---|---|---|---|---|---|---|
| Low | Moderate | High | Low | Moderate | High | ||
| Colorectal cancer | |||||||
| All | |||||||
| No. controls/cases | 222/106 | 213/111 | 235/77 | 219/126 | 229/157 | 208/108 | |
| Crude OR (95% CI) | 1.00 (ref.) | 1.09 (0.79–1.51) | 0.69 (0.49–0.97) | 1.21 (0.88–1.66) | 1.44 (1.06–1.95) | 1.09 (0.78–1.51) | 0.263 |
| Adjusted ORa (95% CI) | 1.00 (ref.) | 0.97 (0.67–1.40) | 0.56 (0.38–0.82) | 1.28 (0.90–1.83) | 1.29 (0.91–1.82) | 0.81 (0.56–1.17) | 0.649 |
| Male | |||||||
| No. controls/cases | 162/109 | 143/48 | 166/49 | 159/120 | 140/65 | 135/76 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.50 (0.33–0.75) | 0.44 (0.29–0.66) | 1.12 (0.80–1.58) | 0.69 (0.47–1.01) | 0.84 (0.58–1.21) | 0.052 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 0.48 (0.30–0.76) | 0.34 (0.21–0.54) | 1.17 (0.79–1.73) | 0.63 (0.41–0.97) | 0.63 (0.41–0.96) | 0.157 |
| Female | |||||||
| No. controls/cases | 72/17 | 63/37 | 64/34 | 65/27 | 79/58 | 78/45 | |
| Crude OR (95% CI) | 1.00 (ref.) | 2.49 (1.28–4.84) | 2.25 (1.15–4.41) | 1.76 (0.88–3.52) | 3.11 (1.66–5.83) | 2.44 (1.28–4.65) | 0.284 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 2.14 (1.03–4.44) | 1.79 (0.84–3.78) | 2.06 (0.96–4.41) | 3.08 (1.55–6.12) | 1.62 (0.79–3.32) | 0.091 |
| Colon cancer | |||||||
| All | |||||||
| No. controls/cases | 222/49 | 213/53 | 235/44 | 219/64 | 229/84 | 208/54 | |
| Crude OR (95% CI) | 1.00 (ref.) | 1.13 (0.73–1.74) | 0.85 (0.54–1.33) | 1.32 (0.87–2.01) | 1.66 (1.12–2.47) | 1.18 (0.77–1.81) | 0.854 |
| Adjusted ORa (95% CI) | 1.00 (ref.) | 1.01 (0.64–1.60) | 0.69 (0.43–1.12) | 1.40 (0.90–2.18) | 1.50 (0.98–2.31) | 0.89 (0.56–1.41) | 0.903 |
| Male | |||||||
| No. controls/cases | 162/49 | 143/22 | 166/28 | 159/53 | 140/35 | 135/41 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.51 (0.20–0.88) | 0.56 (0.33–0.93) | 1.10 (0.71–1.72) | 0.83 (0.51–1.35) | 1.00 (0.63–1.61) | 0.148 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 0.48 (0.27–0.88) | 0.43 (0.24–0.75) | 1.14 (0.71–1.85) | 0.75 (0.44–1.27) | 0.77 (0.46–1.30) | 0.165 |
| Female | |||||||
| No. controls/cases | 72/8 | 63/18 | 64/21 | 65/19 | 79/31 | 78/23 | |
| Crude OR (95% CI) | 1.00 (ref.) | 2.57 (1.05–6.32) | 2.95 (1.22–7.13) | 2.63 (1.08–6.42) | 3.53 (1.52–8.18) | 2.65 (1.12–6.31) | 0.064 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 2.12 (0.81–5.53) | 2.22 (0.85–5.75) | 3.10 (1.19–8.06) | 3.39 (1.39–8.29) | 1.63 (0.64–4.14) | 0.028 |
| Rectal cancer | |||||||
| All | |||||||
| No. controls/cases | 222/57 | 213/57 | 235/32 | 219/57 | 229/72 | 208/53 | |
| Crude OR (95% CI) | 1.00 (ref.) | 1.04 (0.69–1.57) | 0.53 (0.33–0.85) | 1.01 (0.67–1.53) | 1.23 (0.83–1.82) | 0.99 (0.65–1.51) | 0.068 |
| Adjusted ORa (95% CI) | 1.00 (ref.) | 0.91 (0.58–1.43) | 0.42 (0.25–0.70) | 1.10 (0.70–1.71) | 1.08 (0.70–1.66) | 0.72 (0.46–1.14) | 0.196 |
| Male | |||||||
| No. controls/cases | 162/60 | 143/26 | 166/20 | 159/65 | 140/30 | 135/35 | |
| Crude OR (95% CI) | 1.00 (ref.) | 0.49 (0.29–0.82) | 0.33 (0.19–0.56) | 1.10 (0.73–1.67) | 0.58 (0.35–0.95) | 0.70 (0.44–1.13) | 0.081 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 0.47 (0.27–0.84) | 0.25 (0.14–0.46) | 1.16 (0.73–1.84) | 0.52 (0.30–0.90) | 0.50 (0.30–0.85) | 0.166 |
| Female | |||||||
| No. controls/cases | 72/9 | 63/19 | 64/12 | 65/6 | 79/25 | 78/21 | |
| Crude OR (95% CI) | 1.00 (ref.) | 2.41 (1.02–5.71) | 1.50 (0.59–3.79) | 0.74 (0.25–2.19) | 2.53 (1.10–5.78) | 2.15 (0.93–5.01) | 0.472 |
| Adjusted ORb (95% CI) | 1.00 (ref.) | 2.17 (0.87–5.40) | 1.26 (0.47–3.40) | 0.87 (0.28–2.69) | 2.57 (1.08–6.13) | 1.60 (0.65–3.96) | 0.648 |
aAdjusted for age, gender, education, alcohol, family history of CRC, total energy intake.
bAdjusted for age, education, alcohol, family history of CRC, total energy intake.
Physical activity-All: <1116 (low), 1116-<2925 (moderate), ≥2925 (High)
Physical activity-Male: <1386 (low), 1386-<3465 (moderate), ≥3465 (High)
Physical activity-Female: <660 (low), 660-<2079 (moderate), ≥2079 (High)
Figure 1Simplied flow chart for the selection of study subject